Scopio's technology employs full-field imaging and artificial intelligence (AI) decision support with the aim of eliminating manual microscopy. The platform allows full-field images to be shared in real-time over a secure hospital network and captures large scan areas at 100X magnification.

Beckman Coulter and Scopio will expand on the strategic objectives of the partnership in a video interview at the LabPulse booth (#1740) at 2022 AACC.

FDA clears Scopio Labs hematology analysis platform
Medtech firm Scopio Labs announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its X100HT device with peripheral...

Beckman Coulter inks deal with Illumina for NGS library prep
Beckman Coulter Life Sciences has signed an agreement with Illumina to access that company's next-generation sequencing (NGS) technology to incorporate...

Beckman Coulter launches DxU Iris urinalysis system at AACC
Beckman Coulter aims to improve laboratory workflow for processing urinalysis samples with a new automated diagnostic system, DxU Iris, introduced at...

Beckman Coulter launches new COVID-19 IgG test
Beckman Coulter announced it has launched its Access SARS-CoV-2 immunoglobulin G (IgG) test, a fully quantitative, lab-based, IgG serology test that...

Beckman Coulter unveils new tabletop hematology analyzer
Beckman Coulter has introduced the DxH 560 AL, a tabletop hematology analyzer targeted at small and medium-sized labs.